cagrilintide phase 2 Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has well-established weight-loss benefits. Cagrilintide, a long-acting analogue of the satiety hormone amylin, has shown promise for weight loss in early trials. The potential benefit Cagrilintide

Radtke MD, Pitts SJ, Jahns L, Firnhaber G, Loofbourrow BM, Zeng A, et al

Patients with significant medical history (kidney disease, severe asthma, certain medications) should disclose them in the pre-procedure assessment

Weeks 1 to 4: Starting Dose Titration Starting dose is 0.25 milligrams of semaglutide weekly, plus 1,000 micrograms of B12

Common symptoms include: Respiratory: Asthma and shortness of breath Gastrointestinal: Bloating, gassiness, and/or abdominal pain Skin: Hives, rashes, acne, eczema, psoriasis, or dermatitis Neurological: Chronic headaches, brain fog, anxiety, explosive anger Other: flushing, sweats, or feeling hot in the hands and feet How to Know If You Have a Food Sensitivity If you experience skin, respiratory, joint, or kidney stone issues in addition to depression or anxiety, consider trying a 2-3 week elimination diet

For as long as recorded history, competitive sports have played a key role in human culture, providing us with inspiration and entertainment as we watch our favorite athletes vying for a Win